SITE enters Wednesday's Q2 earnings report carrying one of its more charged short-positioning setups in recent memory, with bears meaningfully more committed than they were just weeks ago.
The most striking feature of the current setup is the pace of short accumulation. Short interest has climbed 41% over the past month to 6.4% of the free float — roughly 2.86 million shares — even as it ticked fractionally lower over the past week. That month-long build is the kind of deliberate positioning that reflects a directional bet, not noise. Yet the borrow market tells a very different story: availability remains extraordinarily loose at 2,660% of short interest, with borrow costs running at just 0.46%. There is no squeeze pressure here, and the lending pool is far from strained — availability is actually near the upper end of its recent range, having tightened materially back in late May and early June before unwinding. The ORTEX short score of 43.6 ranks in just the 26th percentile, reinforcing that the short setup, while growing, is not yet at extreme levels.
Options positioning has turned less defensive than usual ahead of the print, which stands in contrast to the bearish short interest trend. The put/call ratio has dropped to 1.31 — nearly 1.6 standard deviations below its 20-day average of 1.60. That is a notable shift: for most of the past month, the PCR ran well above 1.60, touching its 52-week high of 1.98 in late May. The recent softening suggests options traders are not adding fresh downside protection into earnings, even as the stock has fallen 5.9% over the past month to close at $106.66, including a 3.2% drop on Monday alone.
The fundamental debate is well-defined. Bulls point to a company that has delivered 3% year-over-year revenue growth with improving EBITDA margins, a healthy balance sheet (Altman Z-score above 4), and roughly 51% upside to the consensus price target of $160.80. Stifel, which upgraded SITE to Buy in May, trimmed its target slightly to $153 on Sunday — keeping the constructive stance intact while acknowledging near-term pressure. BofA and RBC remain positive, though BofA has cut its target twice this year. Bears counter that the FY'26 revenue growth forecast has been slashed to just +0.5%, new residential construction is softening, and management's EBITDA guidance range of $405–415 million already disappointed against prior expectations. Flat PVC pricing and expected grass seed deflation of 10–15% in the first half add further pressure on margins. UBS downgraded to Neutral in April and cut its target to $140, below the current price — a signal that at least one major firm sees limited near-term upside even at these levels.
History adds an uncomfortable data point: the last earnings event, on April 29, produced a 12% single-day decline and a 14.5% drawdown over the subsequent five trading days. Wednesday's print will test whether the recovery in EBITDA margins is enough to offset what the bears see as a structurally weaker revenue trajectory.
See the live data behind this article on ORTEX.
Open SITE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
